Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.0033113 | uM | 8 | 625.00 | 270.83 | 734.00 | 644.25 | 1.1393 | 1.2199 |
| BT-20 | Linsitinib | 0.1 | uM | 8 | 625.00 | 270.83 | 915.00 | 644.25 | 1.4203 | 1.6479 |
| BT-20 | Lapatinib | 0.1 | uM | 8 | 625.00 | 270.83 | 927.00 | 644.25 | 1.4389 | 1.6756 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 876.00 | 644.25 | 1.3597 | 1.5572 | |
| BT-20 | 17-AAG | 0.000066069 | uM | 8 | 625.00 | 270.83 | 935.00 | 644.25 | 1.4513 | 1.6941 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 899.00 | 644.25 | 1.3954 | 1.6108 | |
| BT-20 | Linsitinib | 0.01 | uM | 8 | 625.00 | 270.83 | 859.00 | 644.25 | 1.3333 | 1.5175 |
| BT-20 | 17-AAG | 0.1 | uM | 8 | 625.00 | 270.83 | 312.00 | 644.25 | 0.4843 | 0.1198 |
| BT-20 | Lapatinib | 0.01 | uM | 8 | 625.00 | 270.83 | 835.00 | 644.25 | 1.2961 | 1.4610 |
| BT-20 | Lapatinib | 0.31623 | uM | 8 | 625.00 | 270.83 | 882.00 | 644.25 | 1.3690 | 1.5712 |
| BT-20 | 17-AAG | 0.31623 | uM | 8 | 625.00 | 270.83 | 302.00 | 644.25 | 0.4688 | 0.0910 |
| BT-20 | Erlotinib | 0.1 | uM | 8 | 625.00 | 270.83 | 722.00 | 644.25 | 1.1207 | 1.1908 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 732.00 | 644.25 | 1.1362 | 1.2151 | |
| BT-20 | Erlotinib | 19.9526 | uM | 8 | 625.00 | 270.83 | 623.00 | 644.25 | 0.9670 | 0.9471 |
| BT-20 | Lapatinib | 0.031623 | uM | 8 | 625.00 | 270.83 | 678.00 | 644.25 | 1.0524 | 1.0834 |
| BT-20 | Lapatinib | 0.0016596 | uM | 8 | 625.00 | 270.83 | 650.00 | 644.25 | 1.0089 | 1.0143 |
| BT-20 | 17-AAG | 0.031623 | uM | 8 | 625.00 | 270.83 | 285.00 | 644.25 | 0.4424 | 0.0416 |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 592.00 | 644.25 | 0.9189 | 0.8692 | |
| BT-20 | 0 | uM | 8 | 625.00 | 270.83 | 511.00 | 644.25 | 0.7932 | 0.6616 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1409.00 | 1673.00 | 0.8422 | 0.7730 | |
| BT-20 | 0 | uM | 8 | 1250.00 | 622.75 | 1404.00 | 1673.00 | 0.8392 | 0.7686 | |
| BT-20 | Erlotinib | 0.01 | uM | 8 | 1250.00 | 622.75 | 1459.00 | 1673.00 | 0.8721 | 0.8169 |
| BT-20 | 17-AAG | 0.000302 | uM | 8 | 1250.00 | 622.75 | 1375.00 | 1673.00 | 0.8219 | 0.7429 |
| BT-20 | Erlotinib | 0.31623 | uM | 8 | 1250.00 | 622.75 | 1826.00 | 1673.00 | 1.0915 | 1.1266 |
| BT-20 | Erlotinib | 1 | uM | 8 | 1250.00 | 622.75 | 1751.00 | 1673.00 | 1.0466 | 1.0650 |